📰 Hyperfine Daily News
Hyperfine Daily News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Hyperfine Daily. Real-time updates on events, politics, business and more.
May 19, 2024
Hyperfine, Inc. (NASDAQ:HYPR – Free Report) – B. Riley increased their Q3 2024 earnings estimates for shares of Hyperfine in a report released on Wednesday, May 15th. B. Riley analyst Y. Zhi now anticipates that the company will post earnings of ($0.13) per share for the quarter, up from their previous estimate of ($0.14). The […]
May 6, 2024
Hyperfine (NASDAQ:HYPR – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Monday, May 13th. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. Hyperfine has set its Q1 2024 guidance at EPS and its FY 2024 guidance at EPS.Parties that wish to […]
February 1, 2024
Hyperfine (NASDAQ:HYPR – Get Free Report) and Fc Global Realty (OTCMKTS:FCRE – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, valuation and earnings. Analyst Recommendations This is a summary of […]
August 7, 2023
Hyperfine (NASDAQ:HYPR – Get Free Report) and CONMED (NYSE:CNMD – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations. Analyst Ratings This is a summary of recent ratings and […]
August 5, 2023
Hyperfine (NASDAQ:HYPR – Get Free Report) and Nexalin Technology (NASDAQ:NXL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Analyst Recommendations This is a breakdown of recent […]
May 10, 2023
Hyperfine (NASDAQ:HYPR – Get Rating) is scheduled to be announcing its earnings results after the market closes on Thursday, May 11th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Hyperfine Stock Down 3.4 […]
April 29, 2023
Hyperfine (NASDAQ:HYPR – Get Rating) and Cutera (NASDAQ:CUTR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings. Insider & Institutional Ownership 27.7% of Hyperfine shares are owned by […]
March 26, 2023
Hyperfine (NASDAQ:HYPR – Get Rating) had its price target cut by B. Riley from $3.50 to $2.50 in a research report released on Wednesday, The Fly reports. They currently have a buy rating on the stock. B. Riley also issued estimates for Hyperfine’s Q1 2023 earnings at ($0.16) EPS, Q2 2023 earnings at ($0.16) EPS, […]
March 24, 2023
Hyperfine, Inc. (NASDAQ:HYPR – Get Rating) – Equities research analysts at B. Riley boosted their FY2023 earnings per share (EPS) estimates for Hyperfine in a research note issued to investors on Tuesday, March 21st. B. Riley analyst N. Chatterji now anticipates that the company will earn ($0.67) per share for the year, up from their […]